The present invention is a product comprising a.beta.2 agonist and aprogestin, as a combined preparation for separate,simultaneous or sequential use in the treatment or prevention of muscle loss.The present invention is also a.beta.2 agonist selectedfrom R,R-formoterol, indacaterol or ritodrine, for use in the treatment orprevention of muscle loss.